Greenphire, a provider of payment technologies for the clinical trials industry, has appointed Alex Livingstone senior director of business development in Europe. Livingstone brings more than 12 years of eClinical software, pharmaceutical and biotechnology industry experience to the company, in a move designed to help Greenphire extend its footprint in European markets.
Based in London, Alex will be responsible for developing market awareness of Greenphire's solutions and will lead the company's overall business development strategy in Europe. Previously, he was global account manager at Phase Forward (now Oracle), where he was charged with driving worldwide sales strategies. He also worked for G.D. Searle prior to its acquisition by Pfizer.